Gregory Flesher is the founder of Reneo Pharmaceuticals. Reneo Pharmaceuticals has raised $95M in total funding. Latest round: Series B.
Gregory J. Flesher is the President and CEO of Reneo Pharmaceuticals, a clinical-stage pharmaceutical company focused on developing therapies for patients with rare genetic mitochondrial diseases. He leads the company's late-stage clinical development of REN001, a PPARδ agonist candidate currently in Phase 2b trials for Primary Mitochondrial Myopathies.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide